PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Paradigm Biopharmaceuticals - My Analysis, Not Mine, page-65

  1. 40 Posts.
    lightbulb Created with Sketch. 23
    Sorry JackSprat12 I meant to open that up to all not just Mozz Is that the case with the phase 2b and upcoming phase 3 trial, that they are part of the EAP and therefore will not show up in the Clinical Trials registry?

    Thanks very much

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.